KLRK1 and prostate carcinoma: Moreover, there is convincing evidence that exosomes derived from diverse cancer cell lines, including mesothelioma, breast and prostate cancer cells, express NKG2D ligands and thereby downregulate NKG2D expression on NK cells and CD8+ T cells, resulting in impaired cytotoxic effector functions [22], [23].